Mir-876 Inhibits Emt And Liver Fibrosis Via Postn To Suppress Metastasis In Hepatocellular Carcinoma (Vol 2020, 1964219, 2020)

Kai Chen,Zhonghu Li,Mengyun Zhang,Bo Wang,Tao Peng,Yanbing Shen,Jianxin Zhang,Jiaxin Ye,Yu Liu,Di Tang,Minjie Peng,Dandan Ma,Zhengkang Xiao,Yujun Zhang,Weidong Jin,Xiaowu Li

DOI: https://doi.org/10.1155/2020/7043985

2020-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/1964219.].

What problem does this paper attempt to address?

Mir-148b Suppresses Cell Proliferation And Invasion In Hepatocellular Carcinoma By Targeting Wnt1/Beta-Catenin Pathway (Vol 5, 8087, 2015)

Jun-gang Zhang,Ying Shi,De-fei Hong,Mengqi Song,Dongsheng Huang,Chun-you Wang,Gang Zhao

DOI: https://doi.org/10.1038/srep46886

IF: 4.6

2017-01-01

Scientific Reports

Abstract:[This corrects the article DOI: 10.1038/srep08087.].
Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

Huajuan Shen,Qiang He,Yongze Dong,Lina Shao,Yueming Liu,Jianguang Gong

DOI: https://doi.org/10.14670/hh-18-242

2020-01-01

Histology and histopathology

Abstract:BACKGROUND:Chronic kidney disease (CKD) has become a major public health issue, which can lead to renal fibrosis regardless of the initial injury. It has been previously reported that miRNA-1228-3p was correlate with the progression of kidney fibrosis. However, the mechanism by which miRNA-1228-3p regulates renal fibrosis remains unclear.METHODS:Renal tubular epithelial cells (HK-2) were treated with TGF-β1 (10 ng/ml) in an in vitro model of renal fibrosis. Gene and protein expressions in HK-2 cells were measured by Western-blot and RT-qPCR, respectively. The relation between miRNA-1228-3p and its target gene was investigated by dual luciferase report analysis.RESULTS:Upregulation of miRNA-1228-3p significantly inhibited TGF-β1-induced fibrosis of HK-2 cells in vitro by targeting GDF11. In addition, miRNA-1228-3p exhibited anti-fibrosis effect through inhibition of the smad2/smad4 signaling pathway.CONCLUSION:Upregulation of miRNA-1228-3p markedly inhibited the progression of renal fibrosis in vitro, indicating that miRNA-1228-3p may serve as a potential novel target for the treatment of renal fibrosis.
Mir-301A-3p Promotes Hepatic Stellate Cells Activation and Liver Fibrogenesis Via Regulating PTEN/PDGFR-β.

Xin Chen,Sai Zhu,Si-Yu Chen,Jia-Nan Wang,Li-Jiao Sun,Shan-Min Tao,Xiao-Feng Li,Hai-Di Li,Ying-Yin Sun,Chuan-Hui Xu,Xiao-Guo Suo,Ming-Lu Ji,Cheng Huang,Xiao-Ming Meng,Jun Li

DOI: https://doi.org/10.1016/j.intimp.2022.109034

IF: 5.714

2022-01-01

International Immunopharmacology

Abstract:Hepatic fibrosis is an essential pathology of multiple chronicliverdiseases. The aim of this study was to investigate the role of miR-301a-3p in hepatic fibrosis. We found that miR-301a-3p was upregulated in hepatic fibrosis patients and in culture-activated human hepatic stellate cells (HSCs). Interestingly, miR-301a-3p expression was increased in hepatic fibrosis progression mice while decreased in hepatic fibrosis recovery mice, indicating that miR-301a-3p may participate in the hepatic fibrosis pathology. Functionally, the effects of miR-301a-3p both on hepatic fibrosis progression and regression were assessed in vivo. Inhibiting miR-301a-3p amelioratedmouse liver fibrogenesis and collagen deposition and suppressed HSC activation and fibrogenic factor expression. Whereas, in hepatic fibrosis regression, upregulating miR-301a-3p impaired mouse hepatic fibrosis recovery by inducing HSC activation and triggering inflammation. Consistently, gain-of-function and loss-of-function analysis of miR-301a-3p were performed to evaluate its effects on human HSCs LX-2 cell. We found that suppressing miR-301a-3p inhibited LX-2 cell activation and proliferation, and induced LX-2 cell apoptosis, accompaniedby decreased fibrotic mediators expression. Collectively, these findings suggest miR-301a-3p drives liver fibrogenesis and HSC activation in hepatic fibrosis. Mechanistically, we demonstrated miR-301a-3p binds directly to phosphatase and tensin homolog (PTEN) by luciferase reporter analysis, pull-down, and RIP assay. Indicating that miR-301a-3p plays a critical rolein promotingliverfibrogenesis viamodulating the PTEN/platelet derived growth factor β (PDGFR-β) pathway. In conclusion, our findings demonstrate that miR-301a-3p expression is closely correlated with hepatic fibrosis pathology, and that enhancing miR-301a-3p maintains the HSC profibrogenic phenotype, triggers inflammatoryresponses, promotes fibrogenic factor production, and further exacerbates liver fibrogenesis. These findings suggest that miR-301a-3p may serve as a promising diagnostic and prognosis biomarker for hepatic fibrosis treatment.
Synergistic Effect Of Mir-146a Mimic And Cetuximab On Hepatocellular Carcinoma Cells (Vol 2014, 384121, 2014)

Suning Huang,Rongquan He,Minhua Rong,Yiwu Dang,Gang Chen

DOI: https://doi.org/10.1155/2020/9375214

2020-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2014/384121.].
Mir-194 is A Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice

Zhipeng Meng,Xianghui Fu,Xiaosong Chen,Samuel Zeng,Yan Tian,Richard Jove,Rongzhen Xu,Wendong Huang

DOI: https://doi.org/10.1002/hep.23915

IF: 17.298

2010-01-01

Hepatology

Abstract:MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by interacting with the 3' untranslated region (3'-UTR) of multiple mRNAs Recent studies have linked miltNAs to the development of cancer metastasis In this study, we show that miR-194 is specifically expressed in the human gastrointestinal tract and kidney Moreover, miR-194 is highly expressed in hepatic epithelial cells, but not in Kupffer cells or hepatic stellate cells, two types of mesenchymal cells in the liver miR-194 expression was decreased in hepatocytes cultured in vitro, which had undergone a dedifferentiation process Furthermore, expression of miR-194 was low in liver mesenchymal-like cancer cell lines The overexpression of miR-194 in liver mesenchymal-like cancer cells reduced the expression of the mesenchymal cell marker N-cadherin and suppressed invasion and migration of the mesenchymal-like cancer cells both in vitro and in vivo We further demonstrated that miR-194 targeted the 3'-UTRs of several genes that were involved in epithelial-mesenchymal transition and cancer metastasis Conclusion These results support a role of miR-194, which is specifically expressed in liver parenchymal cells, in preventing liver cancer cell metastasis (HEPATOLOGY 2010,52 2148-2157)
The Mir-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis Through Altering the Androgen Receptor Signals

Junjie Xu,Hui Lin,Gonghui Li,Yin Sun,Jiang Chen,Liang Shi,Xiujun Cai,Chawnshang Chang

DOI: https://doi.org/10.1016/j.ebiom.2016.07.013

IF: 11.205

2016-01-01

EBioMedicine

Abstract:The androgen receptor (AR) was found to suppress hepatocellular carcinoma (HCC) metastasis at late stages. Due to this discovery, we searched for some AR enhancers to increase the efficacy of Sorafenib chemotherapy, and identified the microRNA (miR)-367-3p, whose expression is positively correlated with AR expression in advanced HCC, as an HCC metastasis suppressor. Combining miR-367-3p with Sorafenib showed better efficacy to suppress HCC cell invasion in vitro and in vivo. Mechanism dissection revealed that miR-367-3p could increase AR expression via directly targeting the 3′UTR of MDM2 to decrease MDM2 protein expression. The resultant increase of AR expression might then promote the expression of FKBP5 and PHLPP, thus dephosphorylating and inactivating AKT and ERK, to suppress the HCC cell invasion. Interestingly, the suppression of pAKT by miR-367-3p could subsequently attenuate the phosphorylation of AR and MDM2, giving rise to additional enhancement of AR protein expression, effectively forming a positive feedback loop. Together, these results suggest that miR-367-3p may function as an AR enhancer to increase Sorafenib chemotherapy efficacy via altering the MDM2/AR/FKBP5/PHLPP/(pAKT and pERK) signals to better suppress HCC metastasis. Successful development of this newly combined chemotherapy in the future may help us to better suppress the HCC metastasis at late stages.
Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Jiye Feng,Jinbo Wang,Mingliang Chen,Gun Chen,Zongyang Wu,Liping Ying,Qifeng Zhuo,Jianlei Zhang,Weilin Wang

DOI: https://doi.org/10.3892/or.2014.3642

2015-01-01

Abstract:miR-200a suppresses tumor development and progression; however, its role in tumor growth and metastasis of hepatocellular carcinoma (HCC) and the underlying mechanism have not been elucidated. In the present study, we identified that miR-200a was markedly downregulated in HCC and exerted suppressive effects on tumor cell growth and metastasis. We identified that miR-200a suppressed tumor growth and metastasis by directly targeting MACC1. In addition, HCC patients with low miR-200a expression had significantly worse prognosis than those with high expression of miR-200a. These findings suggest that miR-200a may be recognized as a novel potential biomarker to predict the survival of patients with HCCs following liver transplantation.
Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Lan Feng,Xi Chen,Peiyao Li,Yuanfeng Li,Yun Zhai,Xinyi Liu,Qian Jin,Hongxing Zhang,Chaohui Yu,Baocai Xing,Ying Cui,Pengbo Cao,Gangqiao Zhou

DOI: https://doi.org/10.1093/carcin/bgad037

2023-01-01

Carcinogenesis

Abstract:Although emerging evidence has established the roles of miRNAs in hepatocellular carcinoma (HCC), the global functional implication of miRNAs in this malignancy remains largely uncharacterized. Here, we aim to systematically identify novel miRNAs involved in HCC and clarify the function and mechanism of specific novel candidate miRNA(s) in this malignancy. Through an integrative omics approach, we identified ten HCC-associated functional modules and a collection of candidate miRNAs. Among them, we demonstrated that miR-424-3p, exhibiting strong associations with extracellular matrix (ECM), promotes HCC cells migration and invasion in vitro and facilitates HCC metastasis in vivo. We further demonstrated that SRF is a direct functional target of miR-424-3p, and is required for the oncogenic activity of miR-424-3p. Finally, we found that miR-424-3p reduces the interferon pathway by attenuating the transactivation of SRF on STAT1/2 and IRF9 genes, which in turn enhances the matrix metalloproteinases (MMPs)-mediated ECM remodeling. This study provides comprehensive functional relevance of miRNAs in HCC by an integrative omics analysis, and further clarifies that miR-424-3p in ECM functional module plays an oncogenic role via reducing the SRF-STAT1/2 axis in this malignancy.
Mir-612 Suppresses the Invasive-Metastatic Cascade in Hepatocellular Carcinoma.

Zhong-Hua Tao,Jin-Liang Wan,Ling-Yao Zeng,Lu Xie,Hui-Chuan Sun,Lun-Xiu Qin,Lu Wang,Jian Zhou,Zheng-Gang Ren,Yi-Xue Li,Jia Fan,Wei-Zhong Wu

DOI: https://doi.org/10.1084/jem.20120153

2013-01-01

Abstract:MicroRNAs (miRNAs) play a critical role in tumor metastasis. In this study, we identified a set of 32 miRNAs involved in hepatocellular carcinoma (HCC) metastasis. Among them, miR-612 was shown for the first time to have inhibitory effects on HCC proliferation, migration, invasion, and metastasis. AKT2 was verified to be one of the direct targets of miR-612, through which the epithelial-mesenchymal transition (EMT) and metastasis were inhibited. The level of miR-612 in HCC patients was inversely associated with tumor size, stage, EMT, and metastasis. Of particular importance, miR-612 is involved in both the initial and final steps of the metastatic cascade, by suppressing local invasion and distant colonization. The pleiotropic roles of miR-612 in the HCC metastatic cascade suggest that it could be an effective target for both early and advanced HCC.
Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

Li-Pei Wu,Jian Wu,Anquan Shang,Man Yang,Ling-Ling Li,Jing Yu,Lei-Rong Xu,Chun-Bing Wang,Wei-Wei Wang,Jian-Jun Zhu,Wen-Ying Lu

DOI: https://doi.org/10.1080/21691401.2017.1415918

2017-01-01

Abstract:Hepatocarcinoma is one of the most lethal malignancy haunting the Chinese population, which is partially due to the difficulties in diagnosis at an early stage. The search for a biomarker that could signify the presence and progress of hepatocarcinoma is never ended. MicroRNAs are 22-nt RNAs that could bind to 3' UTR of target mRNAs, mediating degradation of mRNAs or inhibiting the translation. Although much has been investigated, the role of miR-124 in hepatocarcinoma remained elusive. We first detected aberrant expression level of miR-124 in HCC tissues of 112 patients. By exploring the clinical parameters, we found a significantly inverse correlation between miR-124 level and TNM stages. Consistent with this, the survival analysis indicated the association of low miR-124 with longer survival time. Subsequent forced expression miR-124 resulted in reduced cell viability of Hep3B and SMMC-7221, which cell lines have high and low background expression of miR-124, respectively. TargetScan prediction rendered a subset of target candidates, which were selected for experimental validation, KLF4 was subject to luciferase assay. Ectopic expression of KLF4 increased the sphere formation ability and CD44/133-positive cell numbers, which can be reversed by abundant expression of miR-124, suggesting that KLF4 is a functional target of miR-124 in tumourigenesis and cancer progression of HCC.
Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

Yongmei Chang,Wensen Yan,Cong Sun,Qingfeng Liu,Jun Wang,Mingzhi Wang

DOI: https://doi.org/10.3892/ol.2017.7092

2017-01-01

Oncology Letters

Abstract:Lung cancer is one of the most common types of tumors and the leading cause of cancer-associated mortality in the world. Additionally, non-small cell lung cancer (NSCLC) accounts for ~80% of all lung cancer cases. Epithelial-mesenchymal transition (EMT) is an important cell biological process, which is associated with cancer migration, metastasis, asthma and fibrosis in the lung. In the present study, it was revealed that miR-145-5p was able to suppress EMT by inactivating the c-Jun N-terminal kinase (JNK) signaling pathway in NSCLC cells. Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) was predicted and confirmed to be a novel target of miR-145-5p. Overexpression of MAP3K1 was able to reverse the inhibition of EMT induced by miR-145-5p via the JNK signaling pathway. Overall, the results revealed that miR-145-5p inhibits EMT via the JNK signaling pathway by targeting MAP3K1 in NSCLC cells.
Mir-296-5p Suppresses EMT of Hepatocellular Carcinoma Via Attenuating NRG1/ERBB2/ERBB3 Signaling

Dong-Min Shi,Li-Xin Li,Xin-Yu Bian,Xue-Jiang Shi,Li-Li Lu,Hong-Xin Zhou,Ting-Jia Pan,Jian Zhou,Jia Fan,Wei-Zhong Wu

DOI: https://doi.org/10.1186/s13046-018-0957-2

IF: 12.658

2018-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:BACKGROUND:Accumulation of evidence indicates that miRNAs have crucial roles in the regulation of EMT-associated properties, such as proliferation, migration and invasion. However, the underlying molecular mechanisms are not entirely illustrated. Here, we investigated the role of miR-296-5p in hepatocellular carcinoma (HCC) progression.METHODS:In vitro cell morphology, proliferation, migration and invasion were compared between HCC cell lines with up- or down-regulation of miR-296-5p. Immunofluorescence and Western blot immunofluorescence assays were used to detect the expression of EMT markers. Bioinformatics programs, luciferase reporter assay and rescue experiments were used to validate the downstream targets of miR-296-5p. Xenograft nude mouse models were established to observe tumor growth and metastasis. Immunohistochemical assays were conducted to study the relationships between miR-296-5p expression and Neuregulin-1 (NRG1)/EMT markers in human HCC samples and mice.RESULTS:miR-296-5p was prominently downregulated in HCC tissues relative to adjacent normal liver tissues and associated with favorable prognosis. Overexpression of miR-296-5p inhibited EMT along with migration and invasion of HCC cells via suppressing NRG1/ERBB2/ERBB3/RAS/MAPK/Fra-2 signaling in vitro. More importantly, miR-296-5p disrupted intrahepatic and pulmonary metastasis in vivo. NRG1, as a direct target of miR-296-5p, mediates downstream biological responses. In HCC tissues from patients and mice, the levels of miR-296-5p and NRG1 also showed an inverse relationship.CONCLUSIONS:miR-296-5p inhibited EMT-related metastasis of HCC through NRG1/ERBB2/ERBB3/RAS/MAPK/Fra-2 signaling.
Mir-17-5p and Mir-20A-5p Suppress Postoperative Metastasis of Hepatocellular Carcinoma Via Blocking HGF/ERBB3-NF-κB Positive Feedback Loop

Dong-Li Liu,Li-Li Lu,Li-Li Dong,Yang Liu,Xin-Yu Bian,Bao-Feng Lian,Lu Xie,Duo Wen,Dong-Mei Gao,Ai-Wu Ke,Jia Fan,Wei-Zhong Wu

DOI: https://doi.org/10.7150/thno.41365

IF: 11.6

2020-01-01

Theranostics

Abstract:Dysregulation of microRNA (miRNA) is a frequent event in hepatocellular carcinoma (HCC), but little is known whether it is a bystander or an actual player on residual HCC metastasis during liver microenvironment remodeling initiated by hepatectomy. Methods: The differently expressed miRNAs and mRNAs were identified from RNA-seq data. Western blot, qRT-PCR, fluorescence in situ hybridization, immunofluorescence and immunohistochemical were used to detect the expression of miRNA and mRNA in cell lines and patient tissues. The biological functions were investigated in vitro and in vivo. Chromatin immunoprecipitation, proximity ligation and luciferase reporter assay were used to explore the specific binding of target genes. The expression of HGF/ERBB3 signaling was detected by Western blot. Results: In this study, HGF induced by hepatectomy was shown to promote metastasis of residual HCC cells. miR-17-5p and miR-20a-5p were confirmed to play inhibitory roles on HCC metastasis. And ERBB3 was found to be the common target of miR-17-5p and miR-20a-5p. HCC cells with lower levels of miR-17-5p and miR-20a-5p or higher level of ERBB3 were often more sensitive to response HGF stimuli and to facilitate metastatic colonization both in vitro and in vivo experimental systems. Furthermore, HGF reinforced ERBB3 expression by NF-κB transcriptional activity in a positive feedback loop. Of particular importance, HCC patients with lower levels of miR-17-5p and miR-20a-5p or higher level of ERBB3 had significantly shorter OS and PFS survivals after surgical resection. Conclusion: miR-17-5p and miR-20a-5p could suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop and offer a new probable strategy for metastasis prevention after HCC resection.
Mir-345–5P Curbs Hepatic Stellate Cell Activation and Liver Fibrosis Progression by Suppressing Hypoxia-Inducible Factor-1Alpha Expression

Peng Wang,Yuan Fang,Jiannan Qiu,Yan Zhou,Zhongxia Wang,Chunping Jiang

DOI: https://doi.org/10.1016/j.toxlet.2022.09.008

IF: 4.271

2022-01-01

Toxicology Letters

Abstract:Hepatic fibrosis, as a common stage of multiple liver diseases, currently has no effective drug treatment. Emerging evidence shows that miRNAs participate in the progression of liver fibrosis. However, the potential role of miRNAs in hepatic fibrosis is not yet fully understood. Herein, we first confirmed that miR-345-5p expression was significantly decreased in activated hepatic stellate cells (HSCs) and fibrotic livers. Functional analysis showed that overexpression of miR-345-5p in human LX-2 cells suppressed the expression of profibrotic markers and cellular proliferation in vitro. Using a dual-luciferase assay, we demonstrated that miR-345-5p regulates HSC activation by targeting the 3'UTR of HIF-1α mRNA. In addition, overexpression of miR-345-5p in vivo alleviated murine liver fibrosis induced by carbon tetrachloride (CCl4) injection, high-fat diet (HFD) feeding and bile duct ligation (BDL). Furthermore, overexpression of miR-345-5p downregulated the expression of HIF-1α and fibrosis markers in livers from different fibrosis models. Collectively, we conclude that miR-345-5p mediates the activation of HSCs by targeting HIF-1α, which subsequently modulates TGFβ/Smad2/Smad3 signaling. Thus, miR-345-5p may become a novel therapeutic target for the treatment of liver fibrosis.
Mir-182-5p Promotes Hepatocellular Carcinoma Progression by Repressing FOXO3a.

Man-Qing Cao,A-Bin You,Xiao-Dong Zhu,Wei Zhang,Yuan-Yuan Zhang,Shi-Zhe Zhang,Ke-wei Zhang,Hao Cai,Wen-Kai Shi,Xiao-Long Li,Kang-Shuai Li,Dong-Mei Gao,De-Ning Ma,Bo-Gen Ye,Cheng-Hao Wang,Cheng-Dong Qin,Hui-Chuan Sun,Ti Zhang,Zhao-You Tang

DOI: https://doi.org/10.1186/s13045-018-0555-y

IF: 28.5

2018-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing CyclinD1 have mistakenly been duplicated over the Western blot bands intended to represent SGK.
Mir-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis.

Li Zhou,Shunai Liu,Ming Han,Yanhua Ma,Shenghu Feng,Jing Zhao,Hongping Lu,Xiaoxue Yuan,Jun Cheng

DOI: https://doi.org/10.1016/j.omtn.2017.11.010

2017-01-01

Abstract:Recent studies have shown the effect of microRNAs on HSC activation and transformation, which is essential for the pathogenesis of liver fibrosis. In our study, we explored the role of miR-185 in liver fibrosis. Plasma miR-185 was detected in hepatitis B virus-related liver fibrosis patients (S2/3, n = 10) by Illumina HiSeq sequencing, and healthy volunteers were selected (n = 8) as the control group. We found that the plasma miR-185 level in fibrosis patients was significantly downregulated. CCl4-induced fibrosis tissues in mouse livers and TGF-β1-activated HSCs also presented downregulated miR-185 concomitant with an increased expression of RHEB and RICTOR. To explore the correlations, LX-2 cells were transiently transfected with miR-185 mimics. The expression levels of α-SMA, collagen I, and collagen III were decreased as well as RHEB and RICTOR. Inhibition of endogenous miR-185 increased fibrogenic activity. Furthermore, dual-luciferase reporter assays indicated that miR-185 inhibited the expression of RHEB and RICTOR by directly targeting their 3' UTRs. Moreover, silencing RHEB and RICTOR suppressed α-SMA and collagen expression levels. In conclusion, miR-185 prevents liver fibrogenesis by inhibiting HSC activation via inhibition of RHEB and RICTOR. These results provide new insights into the mechanisms behind the anti-fibrotic effect of miR-185.
Research on Promoting Liver Fibrosis Injury by the Targeted Regulation of Mir-202 for HGF to Activate HSC

Zhuhai Campus of Zunyi Medical University,Nong Shirong,Gong Junyuan,Zhang Xin,Tang Hui,Zhou Tianhong,Li Wei

DOI: https://doi.org/10.1007/s11845-020-02210-w

2020-01-01

Abstract:Background Liver fibrosis is the primary cause of liver cirrhosis and hepatocellular carcinoma and leads to considerable morbidity and mortality. Recent studies have shown that microRNAs are associated with fibrotic processes in liver disorders, but the exact role of miR-202 is still unclear, and its related mechanisms are not fully understood. Aims The aim of this research is to analyze the regarded regulation of miR-202 on HGF and its role in the pathological progress of liver fibrosis. Methods In the present study, qRT-PCR was used to detect the expression level of miR-202 in serum of patients with liver fibrosis and to compare its expression in patients with different pathological stages. HGF was predicted to be the target gene of miR-202 by TargetScan and was verified by Dual-luciferase reporter gene assay. qRT-PCR and western blot were used to detect the regulatory effect of mir-202 on the mRNA and protein of HGF; effect of miR-202 on the expression of fibrosis factors α-smooth muscle actin (α-SMA), FSP1, and collagen was detected; effect of miR-202 on liver fibrosis in mice was detected by establishing CCL4-induced mouse model. Results We found that the expression level of miR-202 in serum of patients with liver fibrosis was significantly higher than that of healthy people, and increased with the increase of fibrosis; miR-202 inhibited the expression level of mRNA and protein of HGF by combining with the 3’-UTR of HGF; the expression level of miR-202 significantly increased after hepatic stellate cells (HSC) were stimulated by AngII; the overexpression of miR-202 could up-regulate the expression of fibrotic factors α-SMA, FSP1, and collagen I. In addition, miR-202 up-regulated the expression of collagen I and collagen III in liver tissue of mice with liver fibrosis and promoted the progress of liver fibrosis. Conclusions miR-202 could negatively regulate the expression of target gene HGF, activated HSC, and increased the expression levels of various fibrosis factors, and the pathological process of liver fibrosis injury was promoted.
Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Jun-Hui Sun,Tan-Yang Zhou,Yue-Lin Zhang,Guan-Hui Zhou,Chun-Hui Nie,Tong-Yin Zhu,Sheng-Qun Chen,Bao-Quan Wang,Song Ye,Yan Shen,Hua Guo,Wei-Lin Wang,Shu-Sen Zheng

DOI: https://doi.org/10.18632/oncotarget.24759

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14642.].
Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway

Jian Li,Danli Ye,Peng Shen,Xiaorong Liu,Peirong Zhou,Guifang Zhu,Yangwei Xu,Yun Fu,Xuanqi Li,Jingbo Sun,Jia Xu,Qingling Zhang

DOI: https://doi.org/10.1186/s13046-020-01809-2

2021-01-28

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Mir-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction]

Peide Bai,Wei Li,Zhenghua Wan,Yujuan Xiao,Wen Xiao,Xuegang Wang,Zhun Wu,Kaiyan Zhang,Yongfeng Wang,Bin Chen,Jinchun Xing,Tao Wang

DOI: https://doi.org/10.2147/cmar.s295016

2020-01-01

Cancer Management and Research

Abstract:[This retracts the article DOI: 10.2147/CMAR.S239796.].

Mir-876 Inhibits Emt And Liver Fibrosis Via Postn To Suppress Metastasis In Hepatocellular Carcinoma (Vol 2020, 1964219, 2020)

Mir-148b Suppresses Cell Proliferation And Invasion In Hepatocellular Carcinoma By Targeting Wnt1/Beta-Catenin Pathway (Vol 5, 8087, 2015)

Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

Mir-301A-3p Promotes Hepatic Stellate Cells Activation and Liver Fibrogenesis Via Regulating PTEN/PDGFR-β.

Synergistic Effect Of Mir-146a Mimic And Cetuximab On Hepatocellular Carcinoma Cells (Vol 2014, 384121, 2014)

Mir-194 is A Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice

The Mir-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis Through Altering the Androgen Receptor Signals

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Mir-612 Suppresses the Invasive-Metastatic Cascade in Hepatocellular Carcinoma.

Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

Mir-296-5p Suppresses EMT of Hepatocellular Carcinoma Via Attenuating NRG1/ERBB2/ERBB3 Signaling

Mir-17-5p and Mir-20A-5p Suppress Postoperative Metastasis of Hepatocellular Carcinoma Via Blocking HGF/ERBB3-NF-κB Positive Feedback Loop

Mir-345–5P Curbs Hepatic Stellate Cell Activation and Liver Fibrosis Progression by Suppressing Hypoxia-Inducible Factor-1Alpha Expression

Mir-182-5p Promotes Hepatocellular Carcinoma Progression by Repressing FOXO3a.

Mir-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis.

Research on Promoting Liver Fibrosis Injury by the Targeted Regulation of Mir-202 for HGF to Activate HSC

Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway

Mir-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction]